#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary amyloidosis Haemophilia B without inhibitors Meningococcal immunisation Leiomyosarcoma recurrent Congenital leptin deficiency Factor IX deficiency NTRK gene fusion overexpression Amyloidosis Erythema Glomerulonephritis rapidly progressive Chronic granulomatous disease Gastrointestinal stromal tumour Penile squamous cell carcinoma Prophylaxis against transplant rejection Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Basic Information Synovial sarcoma – Basic Information Ewing’s sarcoma metastatic – Life with Disease Systemic mastocytosis Alexander disease – Diagnostics Gaucher’s disease type III – Life with Disease Small intestine leiomyosarcoma – Diagnostics Systemic mastocytosis – Basic Information Pulmonary sarcoidosis – Life with Disease Immunodeficiency congenital – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carbamazepine (Ph. Eur.) Eptinezumab Simvastatin Sertindole Leriglitazone Bay 2927088 Savolitinib ALXN2420 Bp1.7881A Sotagliflozin CITRIC ACID ANHYDROUS GRISNILIMAB SETARITOX Df1001 19Cp02 Sodium Hyaluronate [14C] DC-806 Gallium (68Ga) Lumateperone Methyl Aminolevulinate Travoprost More therapies…

    Learn about Your Condition

    Renal injury Pyoderma gangrenosum Angiosarcoma metastatic Asthma Bacterial infection Head and neck cancer stage IV Solitary fibrous tumour Labour pain Lumbosacral radiculopathy Rheumatic disorder Eosinophilic oesophagitis Neutropenia Ventricular fibrillation Hepatic cirrhosis Sickle cell anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Niraparib
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Germany Italy

  • Study on CD8 PET Imaging for Patients with Metastatic Solid Tumors Using 89Zr-Df-crefmirlimab, Nivolumab, and Cetrelimab

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Zirconium (89Zr) Crefmirlimab Berdoxam
    • Cetrelimab
    • Nivolumab
    The Netherlands Spain

  • Study on Mechanical Thrombectomy and Acetylsalicylic Acid for Patients with Acute Ischemic Stroke from Large Vessel Blockage

    Recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Acetylsalicylic Acid
    Poland

  • Study on Pre-Operative Treatment for Breast Cancer Using Nivolumab, Ipilimumab, and Relatlimab for Patients with Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Relatlimab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    The Netherlands

  • Study on Using Perflubutane for Sentinel Node Detection in Patients with Breast Cancer, Melanoma, or Head and Neck Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Head and neck cancer
    • Breast cancer
    Investigated Drugs:
    • Perflubutane
    The Netherlands

  • Study on Recurrent Colorectal Liver Metastases: Evaluating Calcium Folinate, Fluorouracil, Capecitabine, Oxaliplatin, and Irinotecan in a Drug Combination for Eligible Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Capecitabine
    • Fluorouracil
    The Netherlands
Previous Page
1 … 301 302 303 304 305 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!